MX2018009776A - Productos combinados de opiaceo y dispositivo con perfiles de seguridad y eficacia mejorados. - Google Patents
Productos combinados de opiaceo y dispositivo con perfiles de seguridad y eficacia mejorados.Info
- Publication number
- MX2018009776A MX2018009776A MX2018009776A MX2018009776A MX2018009776A MX 2018009776 A MX2018009776 A MX 2018009776A MX 2018009776 A MX2018009776 A MX 2018009776A MX 2018009776 A MX2018009776 A MX 2018009776A MX 2018009776 A MX2018009776 A MX 2018009776A
- Authority
- MX
- Mexico
- Prior art keywords
- opioid
- drug
- self
- prescription
- dispensing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2503/00—Evaluating a particular growth phase or type of persons or animals
- A61B2503/08—Elderly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/11—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring interpupillary distance or diameter of pupils
- A61B3/112—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring interpupillary distance or diameter of pupils for measuring diameter of pupils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/117—Identification of persons
- A61B5/1171—Identification of persons based on the shapes or appearances of their bodies or parts thereof
- A61B5/1172—Identification of persons based on the shapes or appearances of their bodies or parts thereof using fingerprinting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4833—Assessment of subject's compliance to treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/681—Wristwatch-type devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
- A61B5/6898—Portable consumer electronic devices, e.g. music players, telephones, tablet computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/18—General characteristics of the apparatus with alarm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/609—Biometric patient identification means
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Diabetes (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Eye Examination Apparatus (AREA)
Abstract
La presente invención describe un novedoso sistema dispensador de opiáceos orales compuesto por una aplicación específica de opiáceos móvil que usa un algoritmo de dispensación de medicamentos específico para el paciente y el medicamento que incorpora el uso de información/valores de autoevaluación, auto-prueba y/o auto-reporte, receta y dispensador capturados digitalmente y por el paciente para: (i) controlar la administración de opiáceos para mejorar la seguridad de los medicamentos, (ii) personalizar la farmacoterapia oral, (iii) mejorar la eficacia de los medicamentos al tiempo que se evitan los efectos secundarios mediados por medicamentos, (iv) disminuye el uso indebido, el abuso, sobre dosificación, sub dosificación, dependencia, adicción, divergencia, ingestión accidental, sobredosis y muertes, (v) mejora el manejo de la enfermedad, (vi) garantiza el cumplimiento de la receta, y (vii) promueve la persistencia de la receta de manera rentable en tiempo real.
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662294585P | 2016-02-12 | 2016-02-12 | |
US201662325012P | 2016-04-20 | 2016-04-20 | |
PCT/US2016/046491 WO2017027673A1 (en) | 2015-08-11 | 2016-08-11 | Devices, system and method to control the delivery of oral medications |
US201662375256P | 2016-08-15 | 2016-08-15 | |
US201662375192P | 2016-08-15 | 2016-08-15 | |
US201662416972P | 2016-11-03 | 2016-11-03 | |
US201662427919P | 2016-11-30 | 2016-11-30 | |
US201662432248P | 2016-12-09 | 2016-12-09 | |
US201662432292P | 2016-12-09 | 2016-12-09 | |
US201662432358P | 2016-12-09 | 2016-12-09 | |
US201662432394P | 2016-12-09 | 2016-12-09 | |
PCT/US2017/017665 WO2017139761A1 (en) | 2016-02-12 | 2017-02-13 | Opioid+device combination products with improved safety and efficacy profiles |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018009776A true MX2018009776A (es) | 2018-11-09 |
Family
ID=59563464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018009776A MX2018009776A (es) | 2016-02-12 | 2017-02-13 | Productos combinados de opiaceo y dispositivo con perfiles de seguridad y eficacia mejorados. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP3413781A4 (es) |
JP (1) | JP2019513504A (es) |
CN (1) | CN109068974A (es) |
AU (1) | AU2017218008A1 (es) |
BR (1) | BR112018016420A2 (es) |
CA (1) | CA3014319A1 (es) |
MX (1) | MX2018009776A (es) |
WO (1) | WO2017139761A1 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11282597B2 (en) | 2015-03-27 | 2022-03-22 | Protenus Inc. | Methods and systems for analyzing accessing of drug dispensing systems |
US10803149B2 (en) | 2016-08-25 | 2020-10-13 | Validose Inc. | System and method for controlled medical therapy |
WO2018204921A1 (en) * | 2017-05-05 | 2018-11-08 | QuantaEd, LLC | Systems, methods, and structures for medication adherence |
WO2018236865A1 (en) | 2017-06-20 | 2018-12-27 | Addinex Technologies, Inc. | PRESCRIPTION DRUG ABUSE PREVENTION SYSTEM |
CN117577321A (zh) | 2017-08-08 | 2024-02-20 | 费森尤斯医疗保健控股公司 | 用于治疗和评估慢性肾脏疾病的进程的系统和方法 |
FR3072821B1 (fr) * | 2017-10-19 | 2022-11-04 | Medissimo | Procede de l’observance par la preparation des doses a administrer des medicaments |
US10831911B2 (en) | 2017-12-19 | 2020-11-10 | Industrial Technology Research Institute | Method, computer program product and processing system for generating secure alternative representation |
US12097043B2 (en) | 2018-06-06 | 2024-09-24 | Masimo Corporation | Locating a locally stored medication |
JP7174778B2 (ja) * | 2018-06-06 | 2022-11-17 | マシモ・コーポレイション | オピオイド過剰摂取モニタリング |
US20200098460A1 (en) * | 2018-09-26 | 2020-03-26 | EPIS Holding Company, LLC | Systems and methods for identifying individual doses of medication |
EP3866673A4 (en) * | 2018-10-09 | 2022-09-14 | Inovytec Medical Solutions Ltd. | SYSTEM FOR IMMEDIATE PERSONALIZED TREATMENT OF A PATIENT IN A MEDICAL EMERGENCY |
US11464410B2 (en) | 2018-10-12 | 2022-10-11 | Masimo Corporation | Medical systems and methods |
CN109447830A (zh) * | 2018-10-31 | 2019-03-08 | 南京德益康信息科技有限公司 | 一种用于控制药品开具的方法 |
US20200143925A1 (en) * | 2018-11-05 | 2020-05-07 | Timothy Earl King | Forensic system and method for detecting fraud, abuse, and diversion in the prescriptive use of controlled substances |
US10909261B2 (en) | 2018-12-12 | 2021-02-02 | Industrial Technology Research Institute | Method and computer program product for generating secure alternative representation for numerical datum |
CN110151184A (zh) * | 2019-04-19 | 2019-08-23 | 昆明依利科特科技有限公司 | 非接触式吸毒人员快速检测系统及方法 |
JP7255359B2 (ja) * | 2019-05-29 | 2023-04-11 | コニカミノルタ株式会社 | 情報を通知するためのプログラム、情報通知装置、および、情報を通知するためにコンピューターで実行される方法 |
WO2020251962A1 (en) * | 2019-06-10 | 2020-12-17 | Protenus, Inc. | Methods and systems for analyzing accessing of drug dispensing systems |
CN110378130B (zh) * | 2019-06-18 | 2023-09-19 | 佛山市第一人民医院(中山大学附属佛山医院) | 基于角色的麻精类药品处方访问控制方法及装置 |
US20210290184A1 (en) | 2020-03-20 | 2021-09-23 | Masimo Corporation | Remote patient management and monitoring systems and methods |
JP7423815B2 (ja) * | 2020-10-20 | 2024-01-29 | セトラスホールディングス株式会社 | 治験管理装置、治験管理方法、治験管理プログラム及び治験管理システム |
CN114667964B (zh) * | 2020-12-24 | 2023-11-14 | 中国科学院脑科学与智能技术卓越创新中心 | 一种非人灵长类药物成瘾性评估的方法与应用 |
CN113197782A (zh) * | 2021-05-20 | 2021-08-03 | 新疆维吾尔自治区人民医院 | 多功能智能提醒药箱 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020024633A1 (en) * | 1999-04-09 | 2002-02-28 | Daehoon Kim | Pupil evaluation system |
CN1771881A (zh) * | 2005-11-10 | 2006-05-17 | 昆明依利科特科技有限公司 | 快速鉴别阿片类毒品吸毒人员成瘾及其依赖程度的方法 |
US8357114B2 (en) * | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
US20070260491A1 (en) * | 2006-05-08 | 2007-11-08 | Pamela Palmer | System for delivery and monitoring of administration of controlled substances |
US9542847B2 (en) * | 2011-02-16 | 2017-01-10 | Toyota Motor Engineering & Manufacturing North America, Inc. | Lane departure warning/assistance method and system having a threshold adjusted based on driver impairment determination using pupil size and driving patterns |
WO2013006905A1 (en) * | 2011-07-13 | 2013-01-17 | White Cell Rx Holdings Pty Ltd | Medication management system |
US9361431B2 (en) * | 2012-04-03 | 2016-06-07 | Gen-9, Inc. | Methods and systems to secure control and enhance medication adherence |
US9579457B2 (en) * | 2013-03-15 | 2017-02-28 | Flint Hills Scientific, L.L.C. | Method, apparatus and system for automatic treatment of pain |
EP2799009A1 (en) * | 2013-04-29 | 2014-11-05 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Non-invasive method for prediction of opioid-analgesia and opioid-blood-concentrations |
JP6585058B2 (ja) * | 2013-09-19 | 2019-10-02 | チルドレンズ ナショナル メディカル センターChildren’S National Medical Center | 患者の生理的摂動を決定するための装置と方法 |
US10289806B2 (en) * | 2013-11-14 | 2019-05-14 | Elwha Llc | Devices, systems, and methods for automated medical product or service delivery |
EP3136948B1 (en) * | 2014-04-29 | 2022-06-08 | Dignity Health | Systems and methods for non-intrusive drug impairment detection |
AU2015301370B2 (en) * | 2014-08-04 | 2020-04-30 | New York University | Methods and kits for diagnosing, assessing or quantitating drug use, drug abuse and narcosis, internuclear ophthalmoplegia, attention deficit hyperactivity disorder (ADHD), chronic traumatic encephalopathy, schizophrenia spectrum disorders and alcohol consumption |
US9357918B1 (en) * | 2014-12-18 | 2016-06-07 | Karen Elise Cohen | System and method for drug screening and monitoring pupil reactivity and voluntary and involuntary eye muscle function |
-
2017
- 2017-02-13 MX MX2018009776A patent/MX2018009776A/es unknown
- 2017-02-13 EP EP17750961.9A patent/EP3413781A4/en not_active Withdrawn
- 2017-02-13 WO PCT/US2017/017665 patent/WO2017139761A1/en active Application Filing
- 2017-02-13 AU AU2017218008A patent/AU2017218008A1/en not_active Abandoned
- 2017-02-13 CA CA3014319A patent/CA3014319A1/en not_active Abandoned
- 2017-02-13 JP JP2018561197A patent/JP2019513504A/ja active Pending
- 2017-02-13 BR BR112018016420A patent/BR112018016420A2/pt not_active IP Right Cessation
- 2017-02-13 CN CN201780023411.4A patent/CN109068974A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3413781A4 (en) | 2020-01-15 |
CN109068974A (zh) | 2018-12-21 |
WO2017139761A1 (en) | 2017-08-17 |
CA3014319A1 (en) | 2017-08-17 |
JP2019513504A (ja) | 2019-05-30 |
EP3413781A1 (en) | 2018-12-19 |
BR112018016420A2 (pt) | 2018-12-26 |
AU2017218008A1 (en) | 2018-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018009776A (es) | Productos combinados de opiaceo y dispositivo con perfiles de seguridad y eficacia mejorados. | |
MX2024000737A (es) | Sistema de administracion, dispositivo de suministro, y dispositivo de notificacion para comunicar el estado de un dispositivo medico. | |
MX2023000320A (es) | Metodos para modular los niveles de farmaco en plasma mediante el uso de eritrohidroxibupropion. | |
GB2538682A (en) | Nasal drug products and methods of their use | |
WO2016007935A3 (en) | Medicine administering system including injection pen and companion device | |
WO2015069773A8 (en) | Devices and methods for continuous drug delivery via the mouth | |
MX2016016380A (es) | Composicion farmaceutica para usarse en la prevencion y/o tratamiento de enfermedades que se desarrollan o progresan como resultado de una disminucion o perdida de actividad del factor viii de coagulacion sanguinea activado. | |
WO2012109022A3 (en) | Medical fluid delivery device programming | |
MX2016008138A (es) | Sistema para el suministro transdermico de ingredientes activos. | |
WO2010042471A3 (en) | Medical devices for delivery of therapeutic agents to body lumens | |
WO2005102058A3 (en) | Multiple unit dose drug delivery system | |
EP3513789A3 (en) | Prophylactic and therapeutic agents for fgfr3 diseases | |
MX2022004258A (es) | Entrega transdermica de cannabidiol. | |
BR112014018450A8 (pt) | Fenilimidazopirazoles substituídos e sua utilização | |
EP3300734A3 (en) | Use of levocetirizine and montelukast in the treatment of autoimmune disorders | |
MX2018013503A (es) | Aparatos, métodos y sistemas para administrar medicamento utilizando kits de medicamento. | |
WO2018102261A3 (en) | Boronic derivatives hydroxamates as anticancer agents | |
MX2019009630A (es) | Programa de dosificacion de un inhibidor de wnt y una molecula de anticuerpo anti-pd-1 en combinacion. | |
EP3518939A4 (en) | THERAPEUTIC COMPLEXES COMPRISING A SMALL MOLECULE COMPLEX DRUG AND A FUNCTIONAL RNA AND NANOPARTICLE ADMINISTRATION VEHICLE | |
PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
GB2534488A (en) | Measured dose dispenser | |
WO2014075203A8 (es) | Nanopartículas con polímero biodegradable y biocompatible plga cargadas con el fármaco de uso humano pentoxfilina | |
WO2015008169A3 (en) | Device, system and method for delivery of a long-acting drug | |
MY197664A (en) | Immunity enhancing agent for cancer by allergin-1 antagonist | |
MX2019010086A (es) | Esquema de dosificacion para una combinacion de ceritinib y una molecula de anticuerpo anti-pd-1. |